annual accounts payable:
$3.61M-$164.00K(-4.35%)Summary
- As of today (September 18, 2025), CDTX annual accounts payable is $3.61 million, with the most recent change of -$164.00 thousand (-4.35%) on December 31, 2024.
- During the last 3 years, CDTX annual accounts payable has risen by +$2.31 million (+177.33%).
- CDTX annual accounts payable is now -21.02% below its all-time high of $4.57 million, reached on December 31, 2020.
Performance
CDTX Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$2.21M-$2.69M(-54.95%)Summary
- As of today (September 18, 2025), CDTX quarterly accounts payable is $2.21 million, with the most recent change of -$2.69 million (-54.95%) on June 30, 2025.
- Over the past year, CDTX quarterly accounts payable has dropped by -$82.00 thousand (-3.58%).
- CDTX quarterly accounts payable is now -56.36% below its all-time high of $5.05 million, reached on March 31, 2024.
Performance
CDTX quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CDTX Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.3% | -3.6% |
| 3 y3 years | +177.3% | -28.6% |
| 5 y5 years | +91.2% | -24.8% |
CDTX Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.3% | +177.3% | -56.4% | +52.5% |
| 5 y | 5-year | -21.0% | +177.3% | -56.4% | +69.6% |
| alltime | all time | -21.0% | >+9999.0% | -56.4% | >+9999.0% |
CDTX Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $2.21M(-55.0%) |
| Mar 2025 | - | $4.90M(+35.7%) |
| Dec 2024 | $3.61M(-4.3%) | $3.61M(+21.6%) |
| Sep 2024 | - | $2.97M(+29.7%) |
| Jun 2024 | - | $2.29M(-54.7%) |
| Mar 2024 | - | $5.05M(+34.0%) |
| Dec 2023 | $3.77M(+160.7%) | $3.77M(+3.0%) |
| Sep 2023 | - | $3.66M(+92.8%) |
| Jun 2023 | - | $1.90M(-52.3%) |
| Mar 2023 | - | $3.98M(+175.1%) |
| Dec 2022 | $1.45M(+11.2%) | $1.45M(-65.9%) |
| Sep 2022 | - | $4.24M(+37.3%) |
| Jun 2022 | - | $3.09M(+8.0%) |
| Mar 2022 | - | $2.86M(+119.9%) |
| Dec 2021 | $1.30M(-71.5%) | $1.30M(-59.9%) |
| Sep 2021 | - | $3.24M(+25.3%) |
| Jun 2021 | - | $2.59M(-19.5%) |
| Mar 2021 | - | $3.21M(-29.6%) |
| Dec 2020 | $4.57M(+142.1%) | $4.57M(+125.7%) |
| Sep 2020 | - | $2.02M(-31.0%) |
| Jun 2020 | - | $2.93M(+14.6%) |
| Mar 2020 | - | $2.56M(+35.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $1.89M(-33.7%) | $1.89M(-29.6%) |
| Sep 2019 | - | $2.68M(+49.9%) |
| Jun 2019 | - | $1.79M(+4.3%) |
| Mar 2019 | - | $1.71M(-39.8%) |
| Dec 2018 | $2.85M(+9.9%) | $2.85M(+16.7%) |
| Sep 2018 | - | $2.44M(-6.6%) |
| Jun 2018 | - | $2.61M(-12.9%) |
| Mar 2018 | - | $3.00M(>+9900.0%) |
| Dec 2017 | $2.59M(-11.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $2.91M(-6.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $3.10M(+163.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $1.18M(+3578.1%) | $0.00 |
| Dec 2013 | $32.00K | - |
FAQ
- What is Cidara Therapeutics, Inc. annual accounts payable?
- What is the all time high annual accounts payable for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. annual accounts payable year-on-year change?
- What is Cidara Therapeutics, Inc. quarterly accounts payable?
- What is the all time high quarterly accounts payable for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. quarterly accounts payable year-on-year change?
What is Cidara Therapeutics, Inc. annual accounts payable?
The current annual accounts payable of CDTX is $3.61M
What is the all time high annual accounts payable for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high annual accounts payable is $4.57M
What is Cidara Therapeutics, Inc. annual accounts payable year-on-year change?
Over the past year, CDTX annual accounts payable has changed by -$164.00K (-4.35%)
What is Cidara Therapeutics, Inc. quarterly accounts payable?
The current quarterly accounts payable of CDTX is $2.21M
What is the all time high quarterly accounts payable for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high quarterly accounts payable is $5.05M
What is Cidara Therapeutics, Inc. quarterly accounts payable year-on-year change?
Over the past year, CDTX quarterly accounts payable has changed by -$82.00K (-3.58%)